argus

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDYINE089A0103198,162 Cr

Timeline

Time (IST)TypeMEventSrc
07 Apr, 07:29 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Sale Of Wholly Owned Subsidiarybse
26 Mar, 02:33 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding 'Allotment of Employee Stock Options'.nse
24 Mar, 07:26 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding 'Revised Code of Practices and Procedures for Fair Disclosures of Un-published Price Sensitive Information.'nse
24 Mar, 07:07 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015bse
23 Mar, 05:36 pmDr Reddys Laboratories Ltd - 500124 - Board Meeting Intimation for Considering The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ending On March 31, 2026bse
21 Mar, 01:59 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 21, 2026, titled "Dr. Reddy s Laboratories announces launch of India s first DCGI-approved Semaglutide injection Obeda® for Type 2 Diabetes.".nse
21 Mar, 07:25 amDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
17 Mar, 05:24 pmDr. Reddy's Laboratories Limited has informed the Exchange about Action(s) taken or orders passednse
17 Mar, 05:18 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
13 Mar, 06:40 pmDr. Reddy's Laboratories Limited has informed the Exchange about General Updatesnse
13 Mar, 06:38 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
12 Mar, 12:27 pmDr. Reddy's Laboratories Limited has informed the Exchange about Allotment of Employee Stock Optionsnse
10 Mar, 11:52 pmDr. Reddy's Laboratories Limited has informed the Exchange about Rumour Verification - Regulation 30(11)nse
10 Mar, 07:59 pmDr. Reddy's Laboratories Limited has informed the Exchange about change in Managementnse
10 Mar, 07:57 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Change in Managementbse
06 Mar, 05:15 pmDr. Reddy's Laboratories Limited has informed the Exchange about General Updatesnse
06 Mar, 05:11 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015bse
05 Mar, 04:04 pmDr. Reddy's Laboratories Limited has informed the Exchange about General Updatesnse
05 Mar, 04:00 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
24 Feb, 05:31 pmDr. Reddy's Laboratories Limited has informed the Exchange about General Updatesnse
24 Feb, 05:26 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of The SEBI Listing Regulationsbse
18 Feb, 07:47 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
18 Feb, 07:45 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 18, 2026, titled "Dr. Reddy's forays into Hormone Replacement Therapy segment with acquisition of Progynova® and Cyclo- Progynova® in India".nse
17 Feb, 03:58 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding 'Allotment of Employee Stock Options'.nse
09 Feb, 06:17 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding Resignation of Mr Sushrut Kulkarni as Other of the company w.e.f. May 08, 2026.nse
09 Feb, 06:08 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Change in Managementbse
27 Jan, 10:48 pmDr. Reddy's Laboratories Limited has informed the Exchange about Transcriptnse
27 Jan, 10:44 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
24 Jan, 12:57 pmDr. Reddy's Laboratories Limited has informed the Exchange about Action(s) initiated or orders passednse
24 Jan, 12:54 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
21 Jan, 10:56 pmDr. Reddy's Laboratories Limited has informed the Exchange about Link of Recordingnse
21 Jan, 10:50 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
21 Jan, 05:06 pmDr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentationnse
21 Jan, 05:06 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
21 Jan, 05:03 pmDr. Reddy's Laboratories Limited has submitted to the Exchange, unaudited financial results for the quarter and nine months ended December 31, 2025.nse
21 Jan, 05:00 pmDr Reddys Laboratories Ltd - 500124 - Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025bse
21 Jan, 04:56 pmDr Reddys Laboratories Ltd - 500124 - Board Meeting Outcome for Outcome Of Board Meetingbse
14 Jan, 04:44 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 14, 2026, titled "Dr. Reddy s announces the first-to-market launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the generic equivalent of Extra-Strength Pataday® Once Daily Relief, in the U.S.".nse
14 Jan, 04:40 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
10 Jan, 07:34 pmDr. Reddy's Laboratories Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015nse
08 Jan, 03:44 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 08, 2026, titled "Intimation of Earnings call".nse
08 Jan, 03:42 pmDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
01 Jan, 03:59 pmDr. Reddy's Laboratories Limited has informed the Exchange about Action(s) taken or orders passednse
01 Jan, 03:50 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
31 Dec, 07:53 pmDr. Reddy's Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015'.nse
23 Dec, 04:25 pmDr Reddys Laboratories Ltd - 500124 - Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ending On December 31, 2025bse
12 Dec, 09:30 pmDr. Reddy's Laboratories Limited has informed the Exchange about General Updatesnse
12 Dec, 09:27 pmDr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015bse
12 Dec, 08:35 amDr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 12, 2025, titled "Dr. Reddy s Laboratories announces Science-Based Net Zero Climate Targets".nse
12 Dec, 08:29 amDr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse